Table 5.
Cox regression analyses for the primary composite endpoint at 30 days by decompensation HF episodes
| Univariable | Multivariable | |||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P value | HR | 95% CI | P value | |
| Total B‐lines sum | 1.04 | 1.01–1.07 | 0.021 | 1.04 | 1.01–1.07 | 0.014 |
| Age | 0.98 | 0.95–1.02 | 0.35 | — | — | — |
| Female sex | 0.60 | 0.20–1.73 | 0.34 | — | — | — |
| NYHA class | 2.48 | 1.09–5.7 | 0.031 | — | — | — |
| LVEF | 1.00 | 0.98–1.03 | 0.91 | — | — | — |
| NT‐proBNP a | 1.00 | 1.00–1.00 | 0.57 | — | — | — |
LVEF, left ventricular ejection fraction; NT‐proBNP, N‐terminal pro‐brain natriuretic peptide; NYHA, New York Heart Association.
a
Per 100 ng/L.